S-adenosylhomocysteine is a more sensitive indicator of renal insufficiency than homocysteine

Nutrition Research

Volumn 24, Issue 7, 2004, Pages 487-494

  Wagner, Conrad ^a   Stone, William J ^a   Koury, Mark J ^a   Dupont, William D ^a   Kerins, David M ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Homocysteine; Renal insufficiency; S adenosylhomocysteine; Vascular disease

Indexed keywords

HOMOCYSTEINE; S ADENOSYLHOMOCYSTEINE;

ARTICLE; BLOOD ANALYSIS; BLOOD LEVEL; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; HUMAN; KIDNEY FAILURE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

EID: 3242812765     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nutres.2004.04.005     Document Type: Article

References (22)

1. Graham I.M., Daly L.E., Refsum H.M., et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA. 277:1997;1775-1781
2. Clarke R., Daly L., Robinson K., Naughten E., Cahalane S., Fowler B., Graham I. Hyperhomocysteinemia an independent risk factor for vascular disease. N Engl J Med. 324:1991;1149-1155
3. Nygard O., Vollset S.E., Refsum H., Brattstrom L., Ueland P.M. Total homocysteine and cardiovascular disease. J Intern Med. 246:1999;425-454
4. Stamler J.S., Loscalzo J. Endothelium-derived relaxing factor modulates the atherothrombogenic effects of homocysteine. J Cardiovasc Pharmacol. 20:1992;S202-204
5. Hajjar K.A., Jacovina A.T. Modulation of annexin II by homocysteine implications for atherothrombosis. J Invest Med. 46:1998;364-369
6. Gow A.J., Cobb F., Stamler J.S. Homocysteine, nitric oxide and nitrosothiols. Carmel R., Jacobsen D.W. Homocystiene in health and disease. 2001;39-45 Cambridge University Press, Cambridge, UK
7. Tsai J.C., Perrella M.A., Yoshizumi M., Hsieh C.M., Haber E., Schlegel R., Lee M.E. Promotion of vascular smooth muscle cell growth by homocysteine a link to atherosclerosis. Proc Natl Acad Sci USA. 91:1994;6369-6373
8. Wang H., Yoshizumi M., Lai K., Tsai J.C., Perrella M.A., Haber E., Lee M.E. Inhibition of growth and p21ras methylation in vascular endothelial cells by homocysteine but not cysteine. J Biol Chem. 272:1997;25380-25385
9. Kerins D.M., Koury M.J., Capdevila A., Rana S., Wagner C. Plasma S-adenosylhomocysteine is a more sensitive indicator of cardiovascular disease than plasma homocysteine. Am J Clin Nutr. 74:2001;723-729
10. Clarke S., Banfield K. S-adenosylmethionine-dependent methyltransferases. Carmel R., Jacobsen D.W. Homocysteine in health and disease. 2001;63-78 Cambridge University Press, Cambridge, UK
11. Perna A.F., Ingrosso D., Zappia V., Galletti P., Capasso G., De Santo N.G. Enzymatic methyl esterification of erythrocyte membrane proteins is impaired in chronic renal failure. Evidence for high levels of the natural inhibitor S-adenosylhomocysteine. J Clin Invest. 91:1993;2497-2503
12. Capdevila A., Wagner C. Measurement of plasma S-adenosylmethionine and S-adenosylhomocysteine as their fluorescent isoindoles. Anal Biochem. 264:1998;180-184
13. Tucker K.L., Selhub J., Wilson P.W., Rosenberg I.H. Dietary intake pattern relates to plasma folate and homocysteine concentrations in the Framingham Heart Study. J Nutr. 126:1996;3025-3031
14. Jacques P.F., Selhub J., Bostom A.G., Wilson P.W., Rosenberg I.H. The effect of folic acid fortification on plasma folate and total homocysteine concentrations [see comments]. N Engl J Med. 340:1999;1449-1454
15. van Guldener C., Robinson K. Homocysteine and renal disease. Semin Thromb Hemost. 26:2000;313-324
16. Bostom A.G., Shemin D., Gohh R.Y., Beaulieu A.J., Jacques P.F., Dworkin L., Selhub J. Treatment of mild hyperhomocysteinemia in renal transplant recipients versus hemodialysis patients. Transplantation. 69:2000;2128-2131
17. Loehrer F.M., Angst C.P., Brunner F.P., Haefeli W.E., Fowler B. Evidence for disturbed S-adenosylmethionine S-adenosylhomocysteine ratio in patients with end-stage renal failure: a cause for disturbed methylation reactions? Nephrol Dial Transplant. 13:1998;656-661
18. Cockcroft D.W., Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron. 16:1976;31-41
19. Armitage P., Berry G. Statistical methods in medical reserch. 1994;Blackwell Science, Oxford, UK
20. Capdevila A., Decha-Umphai W., Song K.H., Borchardt R.T., Wagner C. Pancreatic exocrine secretion is blocked by inhibitors of methylation. Arch Biochem Biophys. 345:1997;47-55
21. Jacob R.A., Gretz D.M., Taylor P.C., James S.J., Pogribny I.P., Miller B.J., Henning S.M., Swendseid M.E. Moderate folate depletion increases plasma homocysteine and decreases lymphocyte DNA methylation in postmenopausal women. J Nutr. 128:1998;1204-1212
22. Mudd S.H., Cerone R., Schiaffino M.C., Fantasia A.R., Minniti G., Caruso U., Lorini R., Watkins D., Matiaszuk N., Rosenblatt D.S., Schwahn B., Rozen R., LeGros L., Kotb M., Capdevila A., Luka Z., Finkelstein J.D., Tangerman A., Stabler S.P., Allen R.H., Wagner C. Glycine N-methyltransferase deficiency a novel inborn error causing persistent isolated hypermethioninaemia. J Inherit Metab Dis. 24:2001;448-464